# OnCo record navdx (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/navdx/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "navdx" ;
  schema:name "NavDx"@en ;
  schema:alternateName "TTMV-HPV DNA test"@en, "NavDx TTMV-HPV DNA"@en, "NavDx" ;
  schema:description "A blood test that counts HPV DNA shed by HPV-driven throat and anal cancers, used to watch for the cancer coming back; Medicare covers it in both."@en ;
  schema:url <https://onco.cc/drugs/navdx/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://navdx.com/>, <https://navdx.com/physician-faqs/>, <https://naveris.com/naveris-receives-medicare-coverage-for-navdx-test/>, <https://naveris.com/naveris-announces-medicare-coverage-of-the-navdx-test-in-anal-cancer-molecular-residual-disease-surveillance/>, <https://www.caredx.com/newsroom/press-releases/caredx-completes-acquisition-of-naveris-extending-leadership-into-high-growth-specialty-oncology>, <https://doi.org/10.1158/1078-0432.CCR-23-1478>, <https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=58376> ;
  onco:status "established" ;
  onco:tag "test" ;
  onco:modality "Tumour-naive circulating tumour HPV DNA test (digital droplet PCR)" ;
  onco:related <https://onco.cc/drugs/radar-mrd/> ;
  onco:cancers <https://onco.cc/cancers/hpv-positive-oropharyngeal-cancer/>, <https://onco.cc/cancers/oropharyngeal-cancer/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/anal/> ;
  onco:technologies <https://onco.cc/technologies/cthpv-dna/>, <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:companies <https://onco.cc/companies/naveris/> ;
  onco:terms <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/ctdna/> .